| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 19.118 | 17.800 | 19.480 | 24.323 | 40.033 | 41.287 | 33.237 | 35.863 | 41.764 | 43.961 |
| Total Income - EUR | 19.118 | 17.800 | 19.480 | 24.323 | 40.033 | 41.287 | 33.237 | 35.863 | 42.525 | 51.472 |
| Total Expenses - EUR | 31.490 | 30.485 | 26.903 | 32.137 | 41.797 | 44.113 | 31.604 | 34.718 | 40.585 | 45.007 |
| Gross Profit/Loss - EUR | -12.372 | -12.685 | -7.423 | -7.814 | -1.764 | -2.825 | 1.633 | 1.145 | 1.940 | 6.464 |
| Net Profit/Loss - EUR | -12.946 | -13.219 | -7.786 | -8.058 | -2.164 | -3.238 | 1.300 | 786 | 1.515 | 5.948 |
| Employees | 1 | 0 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Equinoxmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 17.881 | 19.614 | 21.640 | 20.171 | 9.872 | 8.559 | 8.329 | 7.291 | 8.378 | 8.691 |
| Inventories | 17.714 | 19.414 | 21.534 | 19.887 | 9.833 | 8.487 | 8.171 | 6.906 | 6.869 | 6.173 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 60 | 21 |
| Cash | 167 | 200 | 106 | 284 | 39 | 72 | 158 | 385 | 1.449 | 2.498 |
| Shareholders Funds | -17.233 | -30.276 | -37.550 | -44.918 | -46.213 | -48.575 | -46.197 | -45.554 | -43.902 | -37.708 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 35.114 | 49.890 | 59.190 | 65.089 | 56.084 | 57.134 | 54.526 | 52.846 | 52.344 | 46.429 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4729 - 4729" | |||||||||
| CAEN Financial Year |
4729
|
|||||||||
Comments - Equinoxmed Srl